Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Our common stock trades on the NASDAQ Global Market under the symbol “KRT.” Our common stock commenced public trading on April 15, 2021.
Holders of Common Stock
As of March 14, 2023, we had approximately 41 stockholders of record of our common stock.
Dividends
On November 8, 2022, our board of directors declared a cash dividend of $0.35 per share of common stock. This dividend was paid on November 30, 2022 to the shareholders of record as of the close of business on November 21, 2022. No dividend was declared for the year ended December 31, 2021.
We currently intend to retain all available funds and any future earnings to fund the development and growth of our business. Therefore, we currently do not anticipate paying any further dividends on our common stock for the foreseeable future. There are currently no restrictions on our present ability to pay dividends to stockholders of our common stock, other than those prescribed by Delaware law. However, any future determination to declare cash dividends will be made at the discretion of our board of directors, subject to applicable laws, and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, general business conditions, and other factors that our board of directors may deem relevant.
Securities Authorized for Issuance Under Equity Compensation Plans
The following table provides information as of December 31, 2022, with respect to all of our compensation plans under which equity securities are authorized for issuance:
Number of Securities
To Be Issued Upon Exercise of Outstanding Options, Warrants and Rights Weighted Average Exercise Price of Outstanding Options, Warrants and Rights Number of Securities Remaining Available for Future Issuance
Equity compensation plans approved by stockholders 502,146 (1) $18.58 (2) 1,322,349
Total 502,146 $18.58 1,322,349
(1) This amount consists of (i) 82,146 shares of our common stock subject to unvested restricted stock units granted under the Plan, and (ii) 420,000 shares subject to stock options granted under the Plan.
(2) This number reflects the weighted-average exercise price of outstanding options and has been calculated exclusive of outstanding restricted stock unit awards issued under the Plan.
Sales of Unregistered Securities and Repurchases of Securities
During the fourth quarter of fiscal 2022, the Company did not sell any unregistered securities and did not repurchase any securities.
ITEM 6. [RESERVED]
29
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.